"New drug can slow progress of ovarian cancer by up to six months"
Avastin, also known as bevacizumab, is already widely used in patients with colon cancer, and doctors believe it will become a standard treatment for ovarian cancer, a new trial of 1,500 women shows Avastin delays the advance of the disease by an average of two months, compared with standard chemotherapy. Bevacizumab is the first new drug for 15 years to show an advantage over existing treatments for women with this disease, these results are however preliminary and will not be fully confirmed until early 2013, ovarian cancer, which affects almost 7,000 women a year, is dubbed the “silent killer” because symptoms are often diagnosed too late, about 4,400 women die each year from the disease, which claims the lives of over 85 per cent of patients if found at a late stage when it has spread to other parts of the body, there has been little improvement in overall survival rates since the introduction of the chemotherapy drug paclitaxel 15 years ago.
In the States, that same news is being greeted with “It isn’t effective”, so now those who could be helped by it will have to pay for it themselves. insurance companies here won’t pay if the drug is said to be ineffective, that’s $100,000/year according to the news, interesting that the UK is encouraged by this study and the US isn’t